Connection

KAVISH PATIDAR to Liver Cirrhosis

This is a "connection" page, showing publications KAVISH PATIDAR has written about Liver Cirrhosis.
Connection Strength

6.683
  1. Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2025 May; 10(5):418-430.
    View in: PubMed
    Score: 0.588
  2. Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study. Am J Gastroenterol. 2020 09; 115(9):1505-1512.
    View in: PubMed
    Score: 0.430
  3. Associations Between Mean Arterial Pressure and Poor ICU Outcomes in Critically Ill Patients With Cirrhosis: Is 65 The Sweet Spot? Crit Care Med. 2020 09; 48(9):e753-e760.
    View in: PubMed
    Score: 0.430
  4. Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. J Hepatol. 2020 11; 73(5):1092-1099.
    View in: PubMed
    Score: 0.421
  5. Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis. Clin Transl Gastroenterol. 2019 09; 10(9):e00075.
    View in: PubMed
    Score: 0.402
  6. Admission plasma uromodulin and the risk of acute kidney injury in hospitalized patients with cirrhosis: a pilot study. Am J Physiol Gastrointest Liver Physiol. 2019 10 01; 317(4):G447-G452.
    View in: PubMed
    Score: 0.400
  7. Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis. Hepatology. 2018 07; 68(1):224-233.
    View in: PubMed
    Score: 0.367
  8. No Association Between Quick Sequential Organ Failure Assessment and Outcomes of Patients With Cirrhosis and Infections. Clin Gastroenterol Hepatol. 2017 11; 15(11):1803-1804.
    View in: PubMed
    Score: 0.343
  9. Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis. Dig Dis Sci. 2017 05; 62(5):1173-1179.
    View in: PubMed
    Score: 0.338
  10. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol. 2014 Nov; 109(11):1757-63.
    View in: PubMed
    Score: 0.284
  11. Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Liver Transpl. 2024 Nov 01; 30(11):1106-1115.
    View in: PubMed
    Score: 0.141
  12. Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transpl. 2025 Jan 01; 31(1):24-31.
    View in: PubMed
    Score: 0.141
  13. Medication burden and anticholinergic use are associated with overt HE in individuals with cirrhosis. Hepatol Commun. 2024 08 01; 8(8).
    View in: PubMed
    Score: 0.141
  14. Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2024 Nov 01; 119(11):2259-2266.
    View in: PubMed
    Score: 0.140
  15. Performance of race-neutral eGFR equations in patients with decompensated cirrhosis. Liver Transpl. 2025 Feb 01; 31(2):170-180.
    View in: PubMed
    Score: 0.140
  16. Controversies in terlipressin and transplantation in the United States: How do we MELD the two? Liver Transpl. 2024 Jul 01; 30(7):753-759.
    View in: PubMed
    Score: 0.138
  17. The association between mean arterial pressure and acute kidney injury reversal among patients with decompensated cirrhosis. Hepatology. 2025 Jan 01; 81(1):126-135.
    View in: PubMed
    Score: 0.138
  18. Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study. Liver Transpl. 2024 03 01; 30(3):244-253.
    View in: PubMed
    Score: 0.132
  19. Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis. Aliment Pharmacol Ther. 2023 06; 57(12):1397-1406.
    View in: PubMed
    Score: 0.128
  20. Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective. Clin Gastroenterol Hepatol. 2023 04; 21(4):897-901.e1.
    View in: PubMed
    Score: 0.128
  21. The prognostic impact of acute kidney injury recovery patterns in critically ill patients with cirrhosis. Liver Transpl. 2023 03 01; 29(3):246-258.
    View in: PubMed
    Score: 0.128
  22. Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury. J Hepatol. 2022 07; 77(1):108-115.
    View in: PubMed
    Score: 0.119
  23. Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver Int. 2022 01; 42(1):187-198.
    View in: PubMed
    Score: 0.117
  24. Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis. Clin Transl Gastroenterol. 2020 12 17; 11(12):e00288.
    View in: PubMed
    Score: 0.110
  25. Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment. Am J Gastroenterol. 2020 11; 115(11):1849-1856.
    View in: PubMed
    Score: 0.109
  26. Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy. Dig Dis Sci. 2021 08; 66(8):2603-2609.
    View in: PubMed
    Score: 0.108
  27. Features of Blood Clotting on Thromboelastography in Hospitalized Patients With Cirrhosis. Am J Med. 2020 12; 133(12):1479-1487.e2.
    View in: PubMed
    Score: 0.106
  28. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2016 Apr; 36(4):572-9.
    View in: PubMed
    Score: 0.078
  29. Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium. Aliment Pharmacol Ther. 2024 Sep; 60(6):778-786.
    View in: PubMed
    Score: 0.035
  30. From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury. Hepatology. 2025 Jun 01; 81(6):1878-1897.
    View in: PubMed
    Score: 0.034
  31. Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis. Am J Gastroenterol. 2024 02 01; 119(2):287-296.
    View in: PubMed
    Score: 0.033
  32. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US. J Hepatol. 2023 12; 79(6):1408-1417.
    View in: PubMed
    Score: 0.033
  33. Trends in Racial and Ethnic Disparities in the Receipt of Lifesaving Procedures for Hospitalized Patients With Decompensated Cirrhosis in the US, 2009-2018. JAMA Netw Open. 2023 07 03; 6(7):e2324539.
    View in: PubMed
    Score: 0.033
  34. PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease. Hepatology. 2023 12 01; 78(6):1788-1799.
    View in: PubMed
    Score: 0.033
  35. Cirrhotic cardiomyopathy: Predictors of major adverse cardiac events and assessment of reversibility after liver transplant. J Cardiol. 2023 08; 82(2):113-121.
    View in: PubMed
    Score: 0.032
  36. Confusion assessment method accurately screens for hepatic encephalopathy and predicts short-term mortality in hospitalized patients with cirrhosis. Metab Brain Dis. 2023 06; 38(5):1749-1758.
    View in: PubMed
    Score: 0.032
  37. Measuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1819-1830.e5.
    View in: PubMed
    Score: 0.031
  38. Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With Cirrhosis. J Pain Symptom Manage. 2022 06; 63(6):953-961.
    View in: PubMed
    Score: 0.030
  39. Eight-Fold Increase in Dietary Supplement-Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States. Liver Transpl. 2022 02; 28(2):169-179.
    View in: PubMed
    Score: 0.029
  40. Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1426-e1437.
    View in: PubMed
    Score: 0.029
  41. Insight into an acute hepatitis A outbreak in Indiana. J Viral Hepat. 2021 06; 28(6):964-971.
    View in: PubMed
    Score: 0.028
  42. Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease. BMC Gastroenterol. 2020 Sep 16; 20(1):302.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.